Citrobacter rodentium: Infection, inflammation and the microbiota

Nature Reviews Microbiology

Volumn 12, Issue 9, 2014, Pages 612-623

  Collins, James W ^a   Keeney, Kristie M ^b   Crepin, Valerie F ^a   Rathinam, Vijay A K ^c   Fitzgerald, Katherine A ^c   Finlay, B Brett ^b   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; COLITIS; ENTERITIS; ENTEROBACTERIACEAE INFECTION; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; MUCOSAL IMMUNITY; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUORUM SENSING; REVIEW; TYPE III SECRETION SYSTEM;

ANIMALS; CITROBACTER RODENTIUM; COLITIS; COLON; DIET; ENTEROBACTERIACEAE INFECTIONS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM; HOST-PATHOGEN INTERACTIONS; IMMUNITY, MUCOSAL; INTESTINE, LARGE; MICE; MICROBIOTA; SIGNAL TRANSDUCTION; VIRULENCE;

EID: 84906308300     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3315     Document Type: Review

References (123)

1. Schauer, D. B. & Falkow, S. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61, 4654-4661 (1993).
2. Schauer, D. B. & Falkow, S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect. Immun. 61, 2486-2492 (1993).
3. Deng, W., Vallance, B. A., Li, Y., Puente, J. L. & Finlay, B. B. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol. Microbiol. 48, 95-115 (2003).
4. Frankel, G. & Phillips, A. D. Attaching effacing Escherichia coli and paradigms of Tir-Triggered actin polymerization: Getting off the pedestal. Cell. Microbiol. 10, 549-556 (2008).
5. Frankel, G. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: More subversive elements. Mol. Microbiol. 30, 911-921 (1998).
6. Nataro, J. P. & Kaper, J. B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142-201 (1998).
7. Petty, N. K. et al. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 192, 525-538 (2010).
8. Wong, A. R. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: Even more subversive elements. Mol. Microbiol. 80, 1420-1438 (2011).
9. Mundy, R. et al. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect. Immun. 72, 2288-2302 (2004).
10. Arbeloa, A. et al. Distribution of espM and espT among enteropathogenic and enterohaemorrhagic Escherichia coli. J. Med. Microbiol. 58, 988-995 (2009).
11. Mundy, R. et al. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 48, 795-809 (2003).
12. Mallick, E. M. et al. A novel murine infection model for Shiga toxin-producing Escherichia coli. J. Clin. Invest. 122, 4012-4024 (2012).
13. Chandrakesan, P. et al. Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene 33, 2639-2654 (2013).
14. Higgins, L. M., Frankel, G., Douce, G., Dougan, G. & MacDonald, T. T. Citrobacter rodentium infection in mice elicits a mucosal TH1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infection Immun. 67, 3031-3039 (1999).
15. Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G. & Wiles, S. Citrobacter rodentium of mice and man. Cell. Microbiol. 7, 1697-1706 (2005).
16. Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204 (2007).
17. Hoffmann, C. et al. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect. Immun. 77, 4668-4678 (2009).
18. Clare, S. et al. Enhanced susceptibility to Citrobacter rodentium infection in microRNA 155 deficient mice. Infect. Immun. 81, 723-732 (2013).
19. Wiles, S. et al. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell. Microbiol. 6, 963-972 (2004).
20. Papapietro, O. et al. R-spondin 2 signalling mediates susceptibility to fatal infectious diarrhoea. Nature Commun. 4, 1898 (2013).
21. Borenshtein, D., McBee, M. E. & Schauer, D. B. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 24, 32-37 (2008).
22. Borenshtein, D., Nambiar, P. R., Groff, E. B., Fox, J. G. & Schauer, D. B. Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect. Immun. 75, 3271-3281 (2007).
23. Willing, B. P., Vacharaksa, A., Croxen, M., Thanachayanont, T. & Finlay, B. B. Altering host resistance to infections through microbial transplantation. PLoS ONE 6, e26988 (2011).
24. Ivanov, I. I. et al. Induction of intestinal TH17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
25. Ghosh, S. et al. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G39-G49 (2011).
26. Borenshtein, D. et al. Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice. Infect. Immun. 77, 3639-3650 (2009).
27. Wiles, S., Pickard, K. M., Peng, K., MacDonald, T. T. & Frankel, G. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect. Immun. 74, 5391-5396 (2006).
28. Luperchio, S. A. & Schauer, D. B. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3, 333-340 (2001).
29. Collins, J. W., Meganck, J., Kuo, C., Francis, K. P. & Frankel, G. 4D multimodality imaging of Citrobacter rodentium infections in mice. J. Vis. Exp. http://dx.doi.org/10.3791/50450 (2013).
30. Wiles, S., Dougan, G. & Frankel, G. Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell. Microbiol. 7, 1163-1172 (2005).
31. Wickham, M. E., Brown, N. F., Boyle, E. C., Coombes, B. K. & Finlay, B. B. Virulence is positively selected by transmission success between mammalian hosts. Curr. Biol. 17, 783-788 (2007).
32. Bishop, A. L., Wiles, S., Dougan, G. & Frankel, G. Cell attachment properties and infectivity of host adapted and environmentally adapted Citrobacter rodentium. Microbes Infect. 9, 1316-1324 (2007).
33. Deng, W., Li, Y., Vallance, B. A. & Finlay, B. B. Locus of enterocyte effacement from Citrobacter rodentium: Sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Infect. Immun. 69, 6323-6335 (2001).
34. Deng, W. et al. Dissecting virulence: Systematic and functional anlyses of a pathogenicity island. Proc. Natl Acad. Sci. USA 101, 3597-3602 (2004).
35. Lai, Y., Rosenshine, I., Leong, J. M. & Frankel, G. Intimate host attachment: Enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol. 15, 1796-1808 (2013).
36. Crepin, V. F. et al. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo. Mol. Microbiol. 75, 308-323 (2010).
37. Kelly, M. et al. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74, 2328-2337 (2006).
38. Guttman, J. A., Samji, F. N., Li, Y., Vogl, A. W. & Finlay, B. B. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect. Immun. 74, 6075-6084 (2006).
39. Guttman, J. A. et al. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell. Microbiol. 8, 634-645 (2006).
40. Hemrajani, C. et al. NleH effectors interact with Bax inhibitor 1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl Acad. Sci. USA 107, 3129-3134 (2010).
41. Selyunin, A. S., Reddick, L. E., Weigele, B. A. & Alto, N. M. Selective protection of an ARF1-GTP signaling axis by a bacterial scaffold induces bidirectional trafficking arrest. Cell Rep. 6, 878-891 (2014).
42. Marches, O. et al. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell. Microbiol. 10, 1104-1115 (2008).
43. Sham, H. P. et al. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF ?B and p38 mitogen activated protein kinase activation. Infect. Immun. 79, 3552-3562 (2011).
44. Kim, M. et al. Bacterial interactions with the host epithelium. Cell Host Microbe 8, 20-35 (2010).
45. Kamada, N. et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325-1329 (2012).
46. Gruenheid, S. et al. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 51, 1233-1249 (2004).
47. Hart, E. et al. RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium. Infect. Immun. 76, 5247-5256 (2008).
48. Gueguen, E. & Cascales, E. Promoter swapping unveils the role of the Citrobacter rodentium CTS1 type VI secretion system in interbacterial competition. Appl. Environ. Microbiol. 79, 32-38 (2013).
49. Yang, J., Tauschek, M., Hart, E., Hartland, E. L. & Robins-Browne, R. M. Virulence regulation in Citrobacter rodentium: The art of timing. Microb. Biotechnol. 3, 259-268 (2010).
50. Rutherford, S. T. & Bassler, B. L. Bacterial quorum sensing: Its role in virulence and possibilities for its control. Cold Spring Harb. Perspect. Med. 2, a012427 (2012).
51. Coulthurst, S. J. et al. Quorum sensing has an unexpected role in virulence in the model pathogen Citrobacter rodentium. EMBO Rep. 8, 698-703 (2007).
52. Lawhon, S. D., Maurer, R., Suyemoto, M. & Altier, C. Intestinal short-chain fatty acids alter Salmonella Typhimurium invasion gene expression and virulence through BarA/SirA. Mol. Microbiol. 46, 1451-1464 (2002).
53. Kawai, T. & Akira, S. Toll-like receptor and RIG I like receptor signaling. Ann. NY Acad. Sci. 1143, 1-20 (2008).
54. Gibson, D. et al. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell. Microbiol. 10, 618-631 (2008).
55. Lebeis, S. L., Bommarius, B., Parkos, C. A., Sherman, M. A. & Kalman, D. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 179, 566-577 (2007).
56. Bergstrom, K. S., Sham, H. P., Zarepour, M. & Vallance, B. A. Innate host responses to enteric bacterial pathogens: A balancing act between resistance and tolerance. Cell. Microbiol. 14, 475-484 (2012).
57. Gibson, D. L. et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell. Microbiol. 10, 388-403 (2008).
58. Khan, M. A. et al. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infection Immun. 74, 2522-2536 (2006).
59. Geddes, K. et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nature Med. 17, 837-844 (2011).
60. Zaki, M. H., Lamkanfi, M. & Kanneganti, T. D. The Nlrp3 inflammasome: Contributions to intestinal homeostasis. Trends Immunol. 32, 171-179 (2011).
61. Franchi, L., Eigenbrod, T., Munoz-Planillo, R. & Nunez, G. The inflammasome: A caspase-1 activation platform that regulates immune responses and disease pathogenesis. Nature Immunol. 10, 241-247 (2009).
62. Rathinam, V. A., Vanaja, S. K. & Fitzgerald, K. A. Regulation of inflammasome signaling. Nature Immunol. 13, 333-332 (2012).
63. Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase 11. Nature 479, 117-121 (2011).
64. Gurung, P. et al. Toll or interleukin 1 receptor (TIR) domain-containing adaptor inducing interferon β (TRIF)-mediated caspase 11 protease production integrates Toll-like receptor 4 (TLR4) protein-And Nlrp3 inflammasome-mediated host defense against enteropathogens. J. Biol. Chem. 287, 34474-34483 (2012).
65. Broz, P. et al. Caspase 11 increases susceptibility to Salmonella infection in the absence of caspase 1. Nature 490, 288-291 (2012).
66. Rathinam, V. A. et al. TRIF licenses caspase 11-dependent NLRP3 inflammasome activation by Gram negative bacteria. Cell 150, 606-619 (2012).
67. Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246-1249 (2013).
68. Liu, Z. et al. Role of inflammasomes in host defense against Citrobacter rodentium infection. J. Biol. Chem. 287, 16955-16964 (2012).
69. Khan, M. A. et al. Flagellin-dependent and-independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect. Immun. 76, 1410-1422 (2008).
70. Simmons, C. P. et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infection Immun. 71, 5077-5086 (2003).
71. Vallance, B. A., Deng, W., Knodler, L. A. & Finlay, B. B. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infection Immun. 70, 2070-2081 (2002).
72. Simmons, C. P. et al. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL 12 or IFN γ. J. Immunol. 168, 1804-1812 (2002).
73. Shiomi, H. et al. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infection Immun. 78, 2653-2666 (2010).
74. O'Quinn, D. B., Palmer, M. T., Lee, Y. K. & Weaver, C. T. Emergence of the TH17 pathway and its role in host defense. Adv. Immunol. 99, 115-163 (2008).
75. Spits, H. et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nature Rev. Immunol. 13, 145-149 (2013).
76. Mangan, P. R. et al. Transforming growth factor β induces development of the TH17 lineage. Nature 441, 231-234 (2006).
77. Torchinsky, M. B., Garaude, J., Martin, A. P. & Blander, J. M. Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation. Nature 458, 78-82 (2009).
78. Lawley, T. D. et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995 (2012).
79. Fritz, J. H. et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481, 199-203 (2012).
80. Rodrigues, D. M., Sousa, A. J., Johnson-Henry, K. C., Sherman, P. M. & Gareau, M. G. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J. Infect. Dis. 206, 99-109 (2012).
81. Fanning, S. et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl Acad. Sci. USA 109, 2108-2113 (2012).
82. Collins, J. W. et al. Fermented dairy products modulate C. rodentium induced colonic hyperplasia. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/ jiu205 (2014).
83. Zenewicz, L. A. et al. IL 22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306-5312 (2013).
84. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
85. Ryz, N. R. et al. Active vitamin D (1,25 dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal TH17 responses. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G1299-G1311 (2012).
86. Smith, A. D., Botero, S., Shea-Donohue, T. & Urban, J. F. Jr. The pathogenicity of an enteric Citrobacter rodentium infection is enhanced by deficiencies in the antioxidants selenium and vitamin E. Infect. Immun. 79, 1471-1478 (2011).
87. Ghosh, S. et al. Fish oil attenuates omega 6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS ONE 8, e55468 (2013).
88. Duck, L. W. et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm. Bowel Dis. 13, 1191-1201 (2007).
89. Mondot, S. et al. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm. Bowel Dis. 17, 185-192 (2011).
90. Monteleone, I., Pallone, F. & Monteleone, G. TH17 related cytokines: New players in the control of chronic intestinal inflammation. BMC Med. 9, 122 (2011).
91. Sekirov, I. et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76, 4726-4736 (2008).
92. Bergstrom, K. S. et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6, e1000902 (2010).
93. Wlodarska, M. et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536-1545 (2011).
94. Burger-van Paassen, N. et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: Implications for epithelial protection. Biochem. J. 420, 211-219 (2009).
95. Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045-1059 (2014).
96. Croxen, M. A. & Finlay, B. B. Molecular mechanisms of Escherichia coli pathogenicity. Nature Rev. Microbiol. 8, 26-38 (2010).
97. Raymond, B. et al. Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors. Trends Microbiol. 21, 430-441 (2013).
98. Law, R. J., Gur-Arie, L., Rosenshine, I. & Finlay, B. B. In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb. Perspect. Med. 3, a009977 (2013).
99. Basu, R. et al. TH22 cells are an important source of IL 22 for host protection against enteropathogenic bacteria. Immunity 37,1061-1075 (2012).
100. Gibson, D. L. et al. Interleukin 11 reduces TLR4 induced colitis in TLR2 deficient mice and restores intestinal STAT3 signaling. Gastroenterology 139, 1277-1288 (2010).
101. Ota, N. et al. IL 22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nature Immunol. 12, 941-948 (2011).
102. Tumanov, A. V. et al. Lymphotoxin controls the IL 22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10, 44-53 (2011).
103. Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M. & Kim, C. H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145, 396-406 (2013).
104. Weinstock, G. M. Genomic approaches to studying the human microbiota. Nature 489, 250-256 (2012).
105. Pham, T. A. & Lawley, T. D. Emerging insights on intestinal dysbiosis during bacterial infections. Curr. Opin. Microbiol. 17, 67-74 (2014).
106. Winter, S. E. et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426-429 (2010).
107. Spees, A. M. et al. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. mBio 4, e00430-13 (2013).
108. Barker, N., van de Wetering, M. & Clevers, H. The intestinal stem cell. Genes Dev. 22, 1856-1864 (2008).
109. Diez, E. et al. Identification and characterization of Cri1, a locus controlling mortality during Citrobacter rodentium infection in mice. Genes Immun. 12, 280-290 (2011).
110. Chandrakesan, P. et al. Novel changes in NF-?B activity during progression and regression phases of hyperplasia: Role of MEK, ERK, and p38. J. Biol. Chem. 285, 33485-33498 (2010).
111. Higgins, L. M. et al. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285, 588-591 (1999).
112. Brown, J. B. et al. Epithelial phosphatidylinositol-3 kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection. Infect. Immun. 79, 1863-1872 (2011).
113. Zheng, Y. et al. Interleukin 22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
114. Deng, W. et al. A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium. J. Biol. Chem. 285, 6790-6800 (2010).
115. Hardwidge, P. R. et al. Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli. J. Biol. Chem. 279, 20127-20136 (2004).
116. Hartland, E. L. et al. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol. Microbiol. 32, 151-158 (1999).
117. Kenny, B. Phosphorylation of tyrosine 474 of the enteropathogenic Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating activity and is preceded by additional host modifications. Mol. Microbiol. 31, 1229-1241 (1999).
118. Gruenheid, S. et al. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nature Cell Biol. 3, 856-859 (2001).
119. Wong, A. R., Raymond, B., Collins, J. W., Crepin, V. F. & Frankel, G. The enteropathogenic E. coli effector EspH promotes actin pedestal formation and elongation via WASP-interacting protein (WIP). Cell. Microbiol. 14, 1051-1070 (2012).
120. Campellone, K. G. & Leong, J. M. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol. Microbiol. 56, 416-432 (2005).
121. Brady, M. J., Campellone, K. G., Ghildiyal, M. & Leong, J. M. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell. Microbiol. 9, 2242-2253 (2007).
122. Vingadassalom, D. et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc. Natl Acad. Sci. USA 106, 6754-6759 (2009).
123. Weiss, S. M. et al. IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe 5, 244-258 (2009)..